Seres Therapeutics, Inc. (47) | License Agreements (2)
- Amendment No. 1 to License Agreement, dated March 24, 2022, by and between the Registrant and NHSc Pharma Partners (Filed With SEC on May 4, 2022)
- License Agreement, dated July 1, 2021, by and between the Registrant and NHSc Pharma Partners (Filed With SEC on November 10, 2021)
